(LYKO-A) Lyko - Ratings and Ratios
Exchange: ST • Country: Sweden • Currency: SEK • Type: Common Stock • ISIN: SE0010468918
LYKO-A: Hair Care, Skin Care, Makeup, Fragrances, Health Products
Lyko Group AB (publ) is a leading Nordic player in the personal care and beauty products sector, specializing in the production and distribution of hair care, skin care, makeup, fragrances, and health and wellness products. The company operates an omnichannel business model, serving customers through physical stores and salons, as well as online via Lyko.com and the Lyko app. Its product portfolio extends to hand and foot care, oral hygiene, feminine hygiene, hair removal, supplements, and sex and pleasure products, catering to a broad audience. Established in 2014 and headquartered in Vansbro, Sweden, Lyko Group AB has expanded its operations across the Nordic region and select European markets, including Norway, Finland, Denmark, Germany, the Netherlands, Poland, and Austria. The company has positioned itself as a one-stop destination for personal care needs, combining convenience, quality, and innovation.
Lyko Group AB (publ) is listed on the Stockholm Stock Exchange under the ticker symbol LYKO-A. The company falls under the Personal Care Products sub-industry within the broader consumer staples sector. Its market capitalization stands at approximately 1,929.06 million SEK, reflecting its established presence in the Nordic markets. The stock has shown volatility, with an average 20-day trading volume of 5,303 shares and a current price of 122.80 SEK. Key technical indicators include a 20-day SMA of 115.77, a 50-day SMA of 121.35, and a 200-day SMA of 109.70, suggesting recent upward momentum. The ATR of 5.79 indicates moderate price fluctuations over the short term.
From a fundamental perspective, Lyko Group AB (publ) trades at a trailing P/E of 90.37 and a forward P/E of 31.95, signaling high valuation multiples relative to earnings. The price-to-book ratio of 4.02 highlights a premium on equity, while the price-to-sales ratio of 0.54 suggests reasonable valuation relative to revenue. The return on equity (RoE) of 4.45% reflects modest profitability compared to equity. These metrics collectively point to a growth-oriented company with a strong market position but elevated valuations.
Additional Sources for LYKO-A Stock
LYKO-A Stock Overview
Market Cap in USD | 200m |
Sector | Consumer Defensive |
Industry | Household & Personal Products |
GiC Sub-Industry | Personal Care Products |
IPO / Inception |
LYKO-A Stock Ratings
Growth Rating | -47.0 |
Fundamental | 30.9 |
Dividend Rating | 0.18 |
Rel. Strength | -16.6 |
Analysts | - |
Fair Price Momentum | 100.10 SEK |
Fair Price DCF | 50.02 SEK |
LYKO-A Dividends
Dividend Yield 12m | 0.00% |
Yield on Cost 5y | % |
Annual Growth 5y | 0.00% |
Payout Consistency | 0.7% |
LYKO-A Growth Ratios
Growth Correlation 3m | -24% |
Growth Correlation 12m | -26.4% |
Growth Correlation 5y | -88% |
CAGR 5y | -7.70% |
CAGR/Max DD 5y | -0.09 |
Sharpe Ratio 12m | -0.62 |
Alpha | -18.24 |
Beta | 0.436 |
Volatility | 37.33% |
Current Volume | 4k |
Average Volume 20d | 4k |
As of May 09, 2025, the stock is trading at SEK 115.40 with a total of 4,014 shares traded.
Over the past week, the price has changed by -5.25%, over one month by +4.91%, over three months by +25.43% and over the past year by -8.12%.
Neither. Based on ValueRay Fundamental Analyses, Lyko is currently (May 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 30.92 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of LYKO-A as of May 2025 is 100.10. This means that LYKO-A is currently overvalued and has a potential downside of -13.26%.
Lyko has no consensus analysts rating.
According to ValueRays Forecast Model, LYKO-A Lyko will be worth about 108.7 in May 2026. The stock is currently trading at 115.40. This means that the stock has a potential downside of -5.85%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 131.3 | 13.7% |
Analysts Target Price | - | - |
ValueRay Target Price | 108.7 | -5.8% |